20 Dec, EOD - Indian

SENSEX 78041.59 (-1.49)

Nifty 50 23587.5 (-1.52)

Nifty Bank 50759.2 (-1.58)

Nifty IT 43771.05 (-2.63)

Nifty Midcap 100 56906.75 (-2.82)

Nifty Next 50 68702.65 (-2.72)

Nifty Pharma 22501.85 (-0.86)

Nifty Smallcap 100 18714.3 (-2.19)

20 Dec, EOD - Global

NIKKEI 225 38701.9 (-0.29)

HANG SENG 19720.7 (-0.16)

S&P 6008.5 (1.05)

Login/Signup

You are Here : Home > Research

30-Jul-2024

Pfizer

OP increased 60.32%

'For quarter ending June 2024, standalone Net sales (including other operating income) of Pfizer has increased 5.93% to Rs 562.86 crore compared to quarter ended June 2023.
Operating profit margin has jumped from 20.84% to 31.53%, leading to 60.32% rise in operating profit to Rs 177.49 crore.  Raw material cost as a % of total sales (net of stock adjustments) decreased from 15.70% to 9.50%.   Purchase of finished goods cost rose from 26.78% to 30.88%.   Employee cost decreased from 17.05% to 15.04%.   Other expenses fell from 20.28% to 15.36%.   

Other income up 25.04% to Rs 41.84 crore.  PBIDT rose 52.13% to Rs 219.33 crore.  Provision for interest fell 26.48% to Rs 2.11 crore.  

PBDT rose 53.73% to Rs 217.22 crore.  Provision for depreciation down 6.11% to Rs 14.6 crore.  

Profit before tax grew 61.13% to Rs 202.62 crore.  Provision for tax was expense of Rs...



Pleaselogin & subscribe to view the full report.

More Reports
More Reports View Company Information

  • Results-Analysis   (29-Oct-2024)

    Pfizer

    PAT up 6.3%

  • Results-Analysis   (30-Jul-2024)

    Pfizer

    OP increased 60.32%

  • Results-Analysis   (28-Oct-2023)

    Pfizer

    PAT down 52.11%

  • Results-Analysis   (16-May-2023)

    Pfizer

    PAT up 3.07%